The global next generation sequencing market was valued at USD 5,793.4 million in 2019 and is expected to reach USD 22.16 billion by the year 2027, at a CAGR of 15.9%. Next-generation sequencing non-Sanger based high throughput method of sequencing. Entire next generation sequencing methodology engages a wide range of reagents, kits, equipment, software and tools for the pieces of its entire workflow that includes sample preparation, library preparation & amplification, sequencing, and analysis. Due to the constant innovations in the NGS technologies, there has been a significant decline in the sequencing costs, complexity and turnaround time. Horizons of the NGS applications is expanding, which in turn offers ample opportunities to emerging as well the existing market players.
Illumina, ThermoFisher Scientific, Pacific biosciences, and Oxford Nanopore Technologies are among key innovators of next generation sequencing technologies. Based on the application, individual technologies are conquering the NGS markets across the globe. Illumina’s SBS technology remains the top choice of the researchers across the globe, considering the reducing costs and high precision. Clinical Diagnostic applications of NGS is dominated by ThermoFisher’s semiconductor NGS technology owing it to its less turnaround time. Pacific Biosciences’ long read sequencing technology is paving its success path for the de-novo sequencing applications. Oxford Nanopore remains a key innovator with its long read, portable, real-time sequencing offerings. Despite differences in the technological basis of individual companies, the market players in NGS products & services are focused on providing low cost, efficient, reliable, user friendly, compact and accurate sequencing experience to their customers. Furthermore, bioinformatics tools plays a vital role in the advancement of NGS workflow and analysis, and continues to register significant growth in the global market. Also, NGS services holds more than one fourth of the revenue generated in the global next generation sequencing market and is fragmented in nature, unlike NGS products market.
Top Companies Profiled in the Report Include:
Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Oxford Nanopore Technologies, Ltd. (U.K.), BGI (China), PerkinElmer (U.S.), Agilent Technologies (U.S.), QIAGEN N. V. (Germany), Macrogen Inc. (South Korea), and Eurofins Scientific (Luxembourg)
Get a sample of the report @ URL https://www.reportsanddata.com/sample-enquiry-form/1868
Market Overview:
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.
Request a discount on the report @ URL https://www.reportsanddata.com/discount-enquiry-form/1868
The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.
The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Next Generation Sequencing market in these key regions.
To know more about the report @ URL https://www.reportsanddata.com/press-release/global-next-generation-sequencing-market
Additionally, the report consists a detailed analysis of the segmentation of the Next Generation Sequencing market based on product types and end-use/application offered in the Next Generation Sequencing market.
Product & Service Outlook (Revenue in Million USD; 2017–2027)
- Pre-sequencing Products and Services
- Sample Preparation
- Library Preparation & Target Enrichment
- Quality Control
- NGS Consumables
- NGS Platforms
- Illumina
-
-
- Hiseq Series
- Hiseq X Ten & HiSeq X Five
- Miseq Series
- NextSeq500
- MiniSeq
- NovaSeq
- iSeq
-
-
- Thermo Fisher Scientific
-
-
- Ion PGM
- Ion Proton
- Ion Genestudio
-
-
-
-
- Ion GeneStudio S5 System
- Ion GeneStudio S5 Plus System
- Ion GeneStudio S5 Prime System
-
- Pacific Biosciences
- Pacbio Sequel Systems
-
-
- Oxford Nanopore Technologies
- Other Next-generation Platforms
- Services for NGS Platforms
- Sequencing Services
- Exome & Targeted Sequencing and Custom Panels
- RNA-Seq
- Whole-genome Sequencing and De Novo Sequencing
- Other Services
- Bioinformatics
- NGS Data Analysis Software & Workbenches
- NGS Data Analysis Services
- NGS Storage Management and Cloud Computing Solutions
Technology Outlook (Revenue in Million USD; 2017–2027)
- Sequencing by Synthesis (SBS)
- Ion Semiconductor Sequencing
- Single-molecule Real-time Sequencing (SMRT)
- Nanopore Sequencing
- Other Technologies
Application Outlook (Revenue in Million USD; 2017–2027)
- Diagnostics
- Cancer Diagnostics
- Infectious Disease Diagnostics
- Reproductive Health Diagnostics
- Other Diagnostic Applications
- Drug Discovery
- Agricultural and Animal Research
- Other Applications
End User Outlook (Revenue in Million USD; 2017–2027)
- Academia & Research Centers
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Other End Users
Country-wise regional analysis covers:
- North America
- USA
- Canada
- Mexico
- Europe
- Germany
- France
- UK.
- BENELUX
- Italy
- Spain
- Switzerland
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of MEA
Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
